Haas Matthias, Dimmler Arno, Hohenberger Werner, Grabenbauer Gerhard G, Niedobitek Gerald, Distel Luitpold V
Institute for Pathology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.
BMC Gastroenterol. 2009 Sep 4;9:65. doi: 10.1186/1471-230X-9-65.
Recent evidence suggests that CD4+CD25+FoxP3+ regulatory T-cells (Treg) may be responsible for the failure of host anti-tumour immunity by suppressing cytotoxic T- cells. We assessed the prognostic significance of tumour infiltrating lymphocytes (TIL) in intestinal-type gastric cardiac cancer.
Tumour infiltrating lymphocyte (TIL) subsets and tumour infiltrating macrophages (TIM) were investigated in 52 cases using tissue microarrays. The interrelationship between the cell populations (CD3+, CD8+, CD20+, CD68+, GranzymeB+, FoxP3+) in different compartments and NED-survival was investigated (median follow-up time: 61 months).
Intraepithelial infiltration with TIL and TIM including Treg was generally low and not related to NED-survival. However, patients with large numbers of FoxP3+ Treg in the tumour stroma (>125.9 FoxP3+TILs/mm2) had a median survival time of 58 months while those with low FoxP3+ TIL counts (<125.9 FoxP3+TILs/mm2) had a median survival time of 32 months (p = 0.006). Patients with high versus low stromal CD68+/FoxP3+ cell ratios in primary tumour displayed median survivals of 32 and 55 months, respectively (p = 0.008).
Our results suggest that inflammatory processes within the tumour stroma of gastric intestinal-type adenocarcinomas located at the gastric cardia may affect outcome in two ways. Tumour-infiltrating macrophages are likely to promote carcinogenesis while large numbers of Treg are associated with improved outcome probably by inhibiting local inflammatory processes promoting carcinogenesis. Thus, inhibition of Treg may not be a feasible treatment option in gastric adenocarcinoma.
最近有证据表明,CD4+CD25+FoxP3+调节性T细胞(Treg)可能通过抑制细胞毒性T细胞导致宿主抗肿瘤免疫失败。我们评估了肿瘤浸润淋巴细胞(TIL)在肠型贲门胃癌中的预后意义。
使用组织芯片对52例患者的肿瘤浸润淋巴细胞(TIL)亚群和肿瘤浸润巨噬细胞(TIM)进行研究。研究不同区域的细胞群体(CD3+、CD8+、CD20+、CD68+、颗粒酶B+、FoxP3+)之间的相互关系以及无疾病生存情况(中位随访时间:61个月)。
包括Treg在内的TIL和TIM的上皮内浸润通常较低,且与无疾病生存无关。然而,肿瘤基质中FoxP3+Treg数量较多(>125.9个FoxP3+TILs/mm2)的患者中位生存时间为58个月,而FoxP3+TIL计数较低(<125.9个FoxP3+TILs/mm2)的患者中位生存时间为32个月(p = 0.006)。原发性肿瘤中基质CD68+/FoxP3+细胞比率高与低的患者中位生存期分别为32个月和55个月(p = 0.008)。
我们的结果表明,位于贲门的胃肠型腺癌肿瘤基质内的炎症过程可能通过两种方式影响预后。肿瘤浸润巨噬细胞可能促进致癌作用,而大量Treg可能通过抑制促进致癌的局部炎症过程与较好的预后相关。因此,在胃腺癌中抑制Treg可能不是一种可行的治疗选择。